Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 112

Results For "RMAT"

1562 News Found

Emmes launches Advantage eClinical as a standalone cloud-native clinical technology platform
Biotech | May 12, 2022

Emmes launches Advantage eClinical as a standalone cloud-native clinical technology platform

The cloud platform will empower biotech companies and CROs with an integrated solution for clinical data management and is supported by Emmes specialist data management teams


New two-year Deucravacitinib data show promising results for severe plaque psoriasis
Biotech | May 12, 2022

New two-year Deucravacitinib data show promising results for severe plaque psoriasis

Deucravacitinib is currently under regulatory review in multiple regions, including the U.S., Europe and Japan, and would be the first selective allosteric tyrosine kinase 2 (TYK2) inhibitor approved for the treatment of any disease


DSM, UNICEF and Sight and Life extend global partnership to address malnutrition
Healthcare | May 11, 2022

DSM, UNICEF and Sight and Life extend global partnership to address malnutrition

The partners also aim to expand their work to Latin America for the first time


Indian Pharma Market slips for third month in a row: Anand Rathi
News | May 10, 2022

Indian Pharma Market slips for third month in a row: Anand Rathi

According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)


Emcure launches EmWocal campaign to raise women’s health issues
Healthcare | May 10, 2022

Emcure launches EmWocal campaign to raise women’s health issues

The campaign will be available in nine Indian languages namely Hindi, English, Odia, Marathi, Tamil, Telugu, Kannada, Malayalam and Bengali


Lonza, ALSA Ventures collaborate on providing manufacturing services to biotech firms
Biotech | May 10, 2022

Lonza, ALSA Ventures collaborate on providing manufacturing services to biotech firms

The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking


Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion
Biotech | May 10, 2022

Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion

Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need


Lupin selects HPE GreenLake edge-to-cloud platform
Digitisation | May 09, 2022

Lupin selects HPE GreenLake edge-to-cloud platform

Lupin recognized the need to digitize more applications, improve scalability, decrease risk of security breaches and eliminate critical data loss


Oncocyte completes validation of Therasure transplant monitor test
Biotech | May 08, 2022

Oncocyte completes validation of Therasure transplant monitor test

Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions


SKS Hospital, Salem installs Carestream’s detector for paediatric studies
Hospitals | May 07, 2022

SKS Hospital, Salem installs Carestream’s detector for paediatric studies

This newly designed small-format detector is made up of caesium iodide technology and is extremely high in resolution, capable of capturing the fine detail of smaller anatomical structures present in paediatric patients